Psychedelic Research Group

Psychedelic Research Group

Menu

  • Home
  • Our Research
  • News Articles
  • Blog
  • Article Grid
  • Videos

treatment of addiction

Magic mushrooms ‘less harmful than thought’ , says leading psychiatrist

Magic mushrooms ‘less harmful than thought’ , says leading psychiatrist

Researchers are beginning to look again at how LSD and psilocybin – the active compound in magic mushrooms – might be of benefit in the treatment of addiction, for obsessive compulsive disorder and even, according to one small Swiss study,

The Administrator August 20, 2015August 26, 2015 News Articles Read more

Focus

The Psychedelic Research Group at Imperial focuses on two main research areas:
  1.  The action of psychedelic drugs in the brain.
  2. Their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression.
The group is lead by Dr Robin Carhart-Harris.

Search

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Blog
News Articles
Published Articles

Twitter

Psychedelic Research Group
20 hours ago
Imperial PRG's Twitter avatar
Imperial PRG
@Imperial_PRG

Wowser, this looks cool! t.co/pKuYFp4MJr

  • Reply
  • Retweet 3
  • Like 4
2 days ago
Robin Carhart-Harris's Twitter avatar
Robin Carhart-Harris
@RCarhartHarris

I'll be speaking here tomorrow evening. Please do come along. Thank you kindly. t.co/Xnli57rpwh

Retweeted by Imperial PRG
  • Reply
  • Retweet 6
  • Like 14
2 days ago
Imperial PRG's Twitter avatar
Imperial PRG
@Imperial_PRG

@BeckleyResearch Thank you @BeckleyResearch!

  • Reply
  • Retweet 1
  • Like 2
5 days ago
Imperial PRG's Twitter avatar
Imperial PRG
@Imperial_PRG

Watch “Psychedelic Ceremony Study” on #Vimeo t.co/AMRy21cTDC

  • Reply
  • Retweet 0
  • Like 1
5 days ago
Chris Timmermann's Twitter avatar
Chris Timmermann
@neurodelia

I will be speaking at New Scientis Live, this September. Come along to get the latest on our DMT research. #NSLive t.co/an4AY7A9CQ

Retweeted by Imperial PRG
  • Reply
  • Retweet 5
  • Like 18

F1000 Prime Recommendation

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

Roseman, L., Nutt D.J., Carhart-Harris R.


Access the recommendation on F1000Prime.

Our Papers


  • LSD enhances suggestibility in healthy volunteersLSD enhances suggestibility in healthy volunteers
  • Finding the Self by Losing the SelfFinding the Self by Losing the Self
  • LSD enhances the emotional response to musicLSD enhances the emotional response to music
  • Neural correlates of the LSD experience revealed by multimodal neuroimagingNeural correlates of the LSD experience revealed by multimodal neuroimaging
  • Relative Harms and Benefits of DrugsRelative Harms and Benefits of Drugs

News Articles about us


  • The Trip Treatment – The New YorkerThe Trip Treatment – The New Yorker
  • Can magic mushrooms treat depression? – New Scientist Live 2017Can magic mushrooms treat depression? – New Scientist Live 2017
  • How Psilocybin Improves Your BrainHow Psilocybin Improves Your Brain
  • The Magic Effect Of Psilocybin MushroomsThe Magic Effect Of Psilocybin Mushrooms
  • LSD’s impact on the brain revealed in groundbreaking imagesLSD’s impact on the brain revealed in groundbreaking images

Contact Us

Any questions, please feel free to contact us.

Archives

Copyright © 2018 Psychedelic Research Group. Powered by WordPress. Theme: Spacious by ThemeGrill.